secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-07-09T23:59:59+00:00
Accession:  0001731122-25-000948
Event type: debt
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro exchanges $9.7M secured debt for $16.1M convertible notes, converted to 53.6M shares
--------------------------------------------------------------------------------

- Exchanged $9.7M in secured promissory notes for $16.1M in convertible notes (65% premium).
- Convertible notes immediately converted into 53.6M shares at $0.30/share (premium to market).
- Transaction eliminated $9.7M secured debt; no cash proceeds received by the company.
- Conversion price exceeded July 7 closing price, so no Nasdaq stockholder approval needed.
- Issuance to accredited existing shareholders exempt from registration under Section 4(a)(2)/Reg D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000948/0001731122-25-000948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000948/e6687_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer